Page last updated: 2024-10-30

mesalamine and Ecthyma

mesalamine has been researched along with Ecthyma in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Ecthyma: An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
López-Iñiguez, A1
Pérez-Gutiérrez, MT1
Lambraño-Castillo, D1
Sierra-Madero, JG1

Other Studies

1 other study available for mesalamine and Ecthyma

ArticleYear
Necrotic lesion in an immunosuppressed patient.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2018, Volume: 36, Issue:9

    Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos

2018